
FDA Accepts NDA for Priority Review: Centanafadine for Treatment of ADHD
<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxPYVJwTTFfSnBZdU9nNng4ZmYtNGktOXJjUGZQOXdWd0VxaW9vUVdaWjJMVHh2eUF4TzdhOG9ubHE3cHBtZ3R1VXpaWlVrVEFKZThxV3d1TWNJVDljVVRVOE41NFlpR2w3N3BFbHF1cVJxQ3kxMzIySm9ZYnh5UVZ2TXJIMDRmbmZlZXdRdk1pLXl1cDJteE9CSVcyYzF3TzFGQmJwSVJCdzdVeXF4WlE?oc=5" target="_blank">FDA Accepts NDA for Priority Review: Centanafadine for Treatment of ADHD</a>&nbsp;&nbsp;<font color="#6f6f6f">Psychiatric Times</font>

